about
--LAA Occluder View for post-implantation Evaluation (LOVE)--standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography.Solid Right Ventricular Compression by Intraventricular Septum-Hematoma Induced after Percutaneous Coronary Intervention.Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesLeft atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study.Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytesDesign and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study.Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy.Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathySimultaneous Non-Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms.Clinical and echocardiographic analysis of patients suffering from recurrent takotsubo cardiomyopathy.Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death.Procedural success and intra-hospital outcome related to left atrial appendage morphology in patients that receive an interventional left atrial appendage closure.Takotsubo Syndrome and Embolic Events.Characteristics and long-term outcome of right ventricular involvement in Takotsubo cardiomyopathy.Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention (PCI)-Results of the FERARI study.Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy.Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.Corrigendum: Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress.Age related differences and outcome of patients with Takotsubo syndrome.Bedside implantation of a new temporary vena cava inferior filter - Safety and efficacy results of the European ANGEL-Registry.Impact and management of left ventricular function on the prognosis of Takotsubo syndrome.Takotsubo Cardiomyopathy: Another Form of Cardiorenal Syndrome.Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.β-Blockers and Outcome After Acute Myocardial Infarction.Hormone Status Correlates With Incidence of Heart Failure.Ezetimibe inhibits platelet activation and uPAR expression on endothelial cells.Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI.Clinical outcomes of femoral closure compared to radial compression devices following percutaneous coronary intervention: the FERARI study.Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failure.Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Expression of Inflammation-related Intercellular Adhesion Molecules in Cardiomyocytes In Vitro and Modulation by Pro-inflammatory Agents.Dissecting the diagnosis of biventricular myocarditis.Impact of stress on Takotsubo syndrome.Letter by El-Battrawy et al Regarding Article, "Takotsubo-Like Myocardial Dysfunction in Ischemic Stroke: A Hospital-Based Registry and Systematic Literature Review".Reply to: Diabetes mellitus and Takotsubo syndrome: Dissecting the paradox.Endothelial dysfunction in takotsubo syndrome.Predictors of mortality in Takotsubo cardiomyopathy.Psychiatric Disease Among Patients With Takotsubo Syndrome.
P50
Q27312052-4D197788-6161-4031-BBF5-D290A72CDB40Q27312424-B178E669-7FE3-4332-BF0D-0EB81E7017CAQ28553287-4F205CD9-CE41-488A-B122-6214E8CA0F79Q31040978-15857765-E8B0-4E5A-A248-776BC622931CQ33774097-394ECE01-9619-42C8-A9F4-A427E2F4B67EQ36256691-05B44A5B-A419-4EE8-A2EC-FE4B2CF06188Q37094809-3AEF1E7D-B350-40DB-84BC-A94C82C5A527Q37153534-DC46E4BD-C900-48CD-B048-9C32C0779752Q37556015-1962389E-7750-4BDD-9086-BA5C69FF4DCDQ37597963-EDF1FC71-588E-4855-AE02-51A389F5BE97Q38697997-2CC95497-A8A9-43D3-9466-E6BB2FCE1E50Q38836964-AB137D04-A3AB-4B81-9799-D96F3A6BDCFAQ38956920-2D5D5334-963C-4ABC-99EB-2E262F94E068Q39621988-9DDC2B57-057F-43DA-9E0C-C28B28FBE3DDQ39650396-F534E039-2B92-4E7D-BCBD-729E0B7FC5E2Q41109592-5EAC13E7-FFCA-4141-8C17-3EEAC2A4B7E1Q41147879-9696C6E6-B9D0-42C3-97A8-A73D90FC5074Q42333307-34C4FC3E-359F-4001-B0F9-43E6561D573BQ47158184-C68B38CD-4A7C-4D87-B701-88C5C3AE2E69Q47239555-A1F10F93-C250-49CA-A05C-1F58E0C7915DQ47888067-47063B7B-34CF-4CFA-8072-93F64DED1E97Q48153266-905437CB-ED6C-4076-BBC5-BA4AA7177EDBQ48741700-1C14E3D1-1C52-4C8D-B7FD-9E4FD2B57005Q49958554-43C7BF6A-272B-431B-AE77-A91EDB7EAD9AQ50090981-4E5DFDE0-61F6-4EBE-9898-21FFB56C70DDQ50224675-84BCF194-2547-49AC-81A5-8E69ED0F0FB5Q50928697-D961F91F-0F37-4803-B107-639A3C68FF01Q51112286-DC9C4C4A-7F84-4C43-A687-FB9DD86F4E76Q51542052-4752C39C-CAAD-4CE3-8F4E-53F6D43DB05DQ52561523-B7374840-0AD9-4279-A16B-5D0795BFD881Q52653741-0DAC60CC-BFAF-407B-B753-A9ED1AFB1D56Q52657121-C67422EA-3607-414C-B1BC-4D265936E227Q52873568-58230138-5BBB-4EA7-B6C5-561F7C8F4000Q53218085-7285BEB9-FF23-4166-BDBA-5171EB83CA1EQ53218096-E96146D2-0FA7-4EEB-852B-72F7E16F5BB0Q53620227-4F60925D-00F7-42F4-9A11-0133E05AC0D2Q53624924-02AB914E-5FF1-4AB3-A042-6F727D1DCD18Q53663795-F8B4E0C6-A036-455A-A8AF-4EF4894E545CQ53675275-441647F0-CAE7-4CD3-9B4E-8DDF3F925923Q53691489-A38901DC-DB65-4EA9-90AA-A5EB1BBCEC3D
P50
name
Ibrahim El-Battrawy
@en
type
label
Ibrahim El-Battrawy
@en
prefLabel
Ibrahim El-Battrawy
@en